Chronic pancreatitis is characterized by a slow inflammatory destruction of pancreatic tissue and subsequent fibrosis. Patients present with abdominal pain or signs of pancreatic endocrine or ...

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...

There have been hundreds of cases of acute pancreatitis in people who have also taken Mounjaro, Ozempic and Wegovy.

Data from the medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), shows that since the drugs were licensed there have been hundreds of cases of acute and chronic ...

Some patients who develop acute pancreatitis can see the condition improve on its own. However, it can often require ...

The pathological manifestations of chronic pancreatitis are extremely variable. The structural alterations range from swelling and mild induration of the gland to fibrosis, atrophy, necrosis ...

New figures from the Medicines and Healthcare products Regulatory Agency (MHRA) show the group of drugs that includes Mounjaro, Wegovy, and Ozempic may be associated with inflammation of the pancreas.

Supplementation: Those with chronic pancreatitis are at higher risk for malnutrition (ie. nutrient deficiencies) due to issues with absorption, especially fat soluble vitamins like A, D, E and K ...

Chronic pancreatitis is often associated with severe abdominal pain, as well as with relapsing episodes of acute pancreatitis, especially in patients with ongoing risk factors such as alcohol use.